Invention Grant
- Patent Title: Modulating phosphatase activity in cardiac cells
-
Application No.: US15065507Application Date: 2016-03-09
-
Publication No.: US11213534B2Publication Date: 2022-01-04
- Inventor: Roger J. Hajjar , Federica del Monte , Evangelia Kranias
- Applicant: The University of Cincinnati , The General Hospital Corporation
- Applicant Address: US OH Cincinnati; US MA Boston
- Assignee: The University of Cincinnati,The General Hospital Corporation
- Current Assignee: The University of Cincinnati,The General Hospital Corporation
- Current Assignee Address: US OH Cincinnati; US MA Boston
- Agency: Locke Lord LLP
- Agent Nicholas J. DiCeglie, Jr.
- Main IPC: A61K48/00
- IPC: A61K48/00 ; A61K31/66 ; C07K14/47 ; A01K67/027
Abstract:
Expression of a phosphatase inhibitor in heart cells can be used to treat cardiac disorders, e.g., heart failure. Decreasing phosphatase activity can improve β-adrenergic responsiveness.
Public/Granted literature
- US20180296578A1 MODULATING PHOSPHATASE ACTIVITY IN CARDIAC CELLS Public/Granted day:2018-10-18
Information query
